Helicobacter Pylori InfectionNCT06628089
Knowledge, and Practice of Helicobacter Pylori Infection
An observational study of Helicobacter Pylori Infection, run by Sohag University.
Trial summary
Helicobacter Pylori infection is very common in Our community However, it may be misdiagnosed and treated from the start until the patient present with complications. Therefore, it is essential that primary care physicians have the appropriate knowledge for making adequate decisions and preventing incorrect practices… Read more about this study
- Who is it for?
- Ages 25 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Helicobacter Pylori Infection
- What is being tested?
- Questionnaire
- How many people
- 300 participants
- Where
- No sites listed yet
- Study dates
- Oct 2024to Mar 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 50 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: A questionnaire will be carried to the primary healthcare physicians in Sohag governorate, and they will be asked to answer it .
Who may be able to join
- physicians at primary healthcare units in Sohag governorate
Who cannot join
- Nonmedical personnel
- GIT specialists
- physicians at secondary or tertiary healthcare centers
Trial locations and contacts
No sites are listed yet.
About this study
Official title: Knowledge, and Practice of Helicobacter Pylori Infection Among Primary Healthcare Physicians in Sohag Governorate
Helicobacter Pylori infection is very common in Our community However, it may be misdiagnosed and treated from the start until the patient present with complications. Therefore, it is essential that primary care physicians have the appropriate knowledge for making adequate decisions and preventing incorrect practices that result in elevated costs and absolutely no health benefits for the population. So this study aims to evaluate the knowledge and practice of primary healthcare physicians at Sohag health care units concerning H. Pylori infection.
Read the detailed description
The most common cause of chronic gastritis is Helicobacter pylori, which can also cause serious gastroduodenal diseases in some patients. These include gastric cancer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric and duodenal peptic ulcer disease (PUD). Strong correlations have been shown between H. pylori and a number of extra-gastric illnesses, including vitamin B12 deficiency, idiopathic thrombocytopenic purpura, and unexplained iron-deficiency anemia. Identifying and eliminating H. pylori in people suffering from these conditions is also advised. Furthermore, neurological disorders, cardiovascular disorders, hepatobiliary disorders and autoimmune disorders may be associated with H. pylori infection. Age, ethnicity, degree of hygiene, and social and economic circumstances are risk factors for H. pylori infection An elevated prevalence of gastrointestinal diseases or symptoms (for example, dyspeptic symptoms) in populations where H. pylori infection is high, implies that a large number of subjects receive primary health care.Therefore, it is essential that primary care physicians have the appropriate knowledge for making adequate decisions and preventing incorrect practices that result in elevated costs and absolutely no health benefits for the population.
Since day-to-day clinical practice demonstrates that many healthcare disciplines surprisingly deal with H. pylori infection in the absence of local guidelines on this matter, there has been no study conducted in Sohag Governate evaluated knowledge, practice and attitude about H. pylori among healthcare physicians as of the time I conducted this survey.
- Conditions
- Helicobacter Pylori Infection
- Being tested
- Questionnaire
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnaireOther
A questionnaire for primary healthcare physicians designed to evaluate knowledge about H. Pylori mode of transmission, symptoms, complications and treatment.
| Study group | Role | What they receive |
|---|---|---|
| 1 | A questionnaire about H. Pylori infection, mode of transmission, Symptoms, treatment will be carried to primary health care physicians and will be asked to answer it Receives: Other: Questionnaire | |
| 2 | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
determine the knowledge and practice of primary healthcare physicians at Sohag health care units concerning H. Pylori infection through a written questionnaire and they will be asked to answer it
A questionnaire will be carried to the physicians includes questions about Pylori mode of transmission, symptoms, complications, treatment to assess their knowledge and practice of Pylori infection and correct any wrong management of the disease and decrease the rate of Pylori infection in Shage Governorate
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Oct 2024
- Study startOct 2024 (estimated)
- Primary completionMar 2025 (estimated)
- Study completionMar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Helicobacter Pylori InfectionStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Esraa Kamal Abdelzaher, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06628089
- Sponsor's protocol ID
- EKAbdelzaher
- Status last verified
- Oct 2024
- First submitted
- 1 Oct 2024
- Last updated
- 4 Oct 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 4 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Knowledge, and Practice of Helicobacter Pylori Infection Among Primary Healthcare Physicians in Sohag Governorate
- ClinicalTrials.gov ID
- NCT06628089
- Acronym / sponsor ID
- EKAbdelzaher
- Conditions
- Helicobacter Pylori Infection
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- Oct 2024 (estimated)
- Primary completion
- Mar 2025 (estimated)
- Study completion
- Mar 2025 (estimated)
- First posted
- 4 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Helicobacter Pylori infection is very common in Our community However, it may be misdiagnosed and treated from the start until the patient present with complications. Therefore, it is essential that primary care physicians have the appropriate knowledge for making adequate decisions and preventing incorrect practices that result in elevated costs and absolutely no health benefits for the population. So this study aims to evaluate the knowledge and practice of primary healthcare physicians at Sohag health care units concerning H. Pylori infection.
Detailed description
The most common cause of chronic gastritis is Helicobacter pylori, which can also cause serious gastroduodenal diseases in some patients. These include gastric cancer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric and duodenal peptic ulcer disease (PUD). Strong correlations have been shown between H. pylori and a number of extra-gastric illnesses, including vitamin B12 deficiency, idiopathic thrombocytopenic purpura, and unexplained iron-deficiency anemia. Identifying and eliminating H. pylori in people suffering from these conditions is also advised. Furthermore, neurological disorders, cardiovascular disorders, hepatobiliary disorders and autoimmune disorders may be associated with H. pylori infection. Age, ethnicity, degree of hygiene, and social and economic circumstances are risk factors for H. pylori infection An elevated prevalence of gastrointestinal diseases or symptoms (for example, dyspeptic symptoms) in populations where H. pylori infection is high, implies that a large number of subjects receive primary health care.Therefore, it is essential that primary care physicians have the appropriate knowledge for making adequate decisions and preventing incorrect practices that result in elevated costs and absolutely no health benefits for the population.
Since day-to-day clinical practice demonstrates that many healthcare disciplines surprisingly deal with H. pylori infection in the absence of local guidelines on this matter, there has been no study conducted in Sohag Governate evaluated knowledge, practice and attitude about H. pylori among healthcare physicians as of the time I conducted this survey.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 1 | – | Other: QuestionnaireA questionnaire about H. Pylori infection, mode of transmission, Symptoms, treatment will be carried to primary health care physicians and will be asked to answer it |
| 2 | – | – |
Who may qualify
- Ages
- 25 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- A questionnaire will be carried to the primary healthcare physicians in Sohag governorate, and they will be asked to answer it .
Key inclusion criteria (1 listed)
- physicians at primary healthcare units in Sohag governorate
Key exclusion criteria (3 listed)
- Nonmedical personnel
- GIT specialists
- physicians at secondary or tertiary healthcare centers
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| QuestionnaireA questionnaire for primary healthcare physicians designed to evaluate knowledge about H. Pylori mode of transmission, symptoms, complications and treatment. | Other | 1 |
Primary outcome
determine the knowledge and practice of primary healthcare physicians at Sohag health care units concerning H. Pylori infection through a written questionnaire and they will be asked to answer it
Time frame: 6 months
A questionnaire will be carried to the physicians includes questions about Pylori mode of transmission, symptoms, complications, treatment to assess their knowledge and practice of Pylori infection and correct any wrong management of the disease and decrease the rate of Pylori infection in Shage Governorate
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Oct 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Helicobacter Pylori Infection
RecruitingPhase 3
Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.
Helicobacter Infection
RecruitingPhase 1
Impact of Eradication Therapy on Helicobacter Pylori Infection With Chronic Obstructive Pulmonary Disease:
Chronic Obstructive Pulmonary Disease (COPD), With Poitive H Pylori
RecruitingObservational study
Feasibility and Performance of FFPE qPCR for Detection of Clarithromycin Resistance in Helicobacter Pylori
HELICOBACTER PYLORI INFECTIONS
RecruitingPhase 4
Efficacy and Safety of Linarazen Gluconate Capsules Combined With Amoxicillin (Dual-Drug Therapy) Versus Bismuth-Containing Quadruple Therapy for First-Line Eradication of Helicobacter Pylori Infection
HELICOBACTER PYLORI INFECTIONS
Not yet recruitingObservational study
European Implementation Study on Simultaneous Screening for Gastric and Colorectal Cancers
Helicobacter Pylori Infection, Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
An observational study of Helicobacter Pylori Infection, run by Sohag University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 4 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Esraa Kamal Abd El-zaher, main investigator (+201127842298, esraakamal@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
determine the knowledge and practice of primary healthcare physicians at Sohag health care units concerning H. Pylori infection through a written questionnaire and they will be asked to answer it (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2024.